Table 5 Average cost-effectiveness (CE) and incremental cost-effectiveness (ICE) ratio of assessed antipsychotics versus haloperidol (€, 2009)
From: Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Strategy | Average CE ratio (€/QALY) | ICE ratio (€/QALY gained) versus haloperidol |
|---|---|---|
Amisulpride | 5,792 | 91,584 |
Aripiprazole | 6,386 | 94,558 |
Haloperidol | 4,593 | NA |
Olanzapine | 5,208 | 23,621 |
Paliperidone ER | 4,043 | Dominant |
Risperidone | 4,353 | Dominant |